Gemcitabine Etoposide Cisplatin and Dexamethasone in Patients With Refractory or Relapsed Non-Hodgkins Lymphoma

摘要

Background/AimsTo date, an effective salvage chemotherapy regimen for the treatment of refractory or relapsing non-Hodgkin's lymphoma (NHL) has not been discovered. This study was conducted to evaluate the efficacy and safety of gemcitabine, etoposide, cisplatin, and dexamethasone in relapsed or refractory NHL patients.